Using Allulose to Increase GLP-1: A Natural Path to Metabolic Health and Longevity
© Nils Osmar 2025
This article is a human/AI collaboration. Portions were written by Nils; other others were written by Claude.AI, then verified and expanded on by Nils, who is responsible for any errors.
- © Nils Osmar 2025. October 27, 2025
- This post is not intended as, and should not be taken as, medical advice.
- See full Medical Disclaimer
We’re living through a remarkable moment in medicine. GLP-1 medications like Ozempic and Wegovy have captured global attention, transforming how we think about weight management and metabolic health. But what if there were a natural, food-based approach that works through similar mechanisms – without the needles, prescriptions, side effects, or hefty price tags?
Enter allulose: a rare sugar that’s emerging as a fascinating natural GLP-1 enhancer. Before we dive into this promising compound, let’s understand exactly what GLP-1 is and why it matters so much for healthy longevity.
What is GLP-1 and Why Should You Care?
GLP-1 (Glucagon-Like Peptide-1) is a hormone naturally produced in your gut in response to eating. Think of it as your body’s metabolic conductor, orchestrating several crucial processes:
Blood Sugar Regulation: GLP-1 signals your pancreas to release insulin when blood glucose rises, helping maintain stable blood sugar levels throughout the day.
Appetite Control: It communicates directly with your brain’s satiety centers, reducing hunger and helping you feel satisfied with less food.
Gastric Emptying: GLP-1 slows the rate at which your stomach empties, leading to steadier nutrient absorption and longer-lasting fullness.
Metabolic Optimization: Beyond these immediate effects, GLP-1 influences fat metabolism, inflammation, and even cardiovascular health.
For those focused on longevity, these effects are particularly intriguing. Maintaining healthy blood sugar, avoiding obesity, and reducing metabolic inflammation are all associated with healthspan – not just living longer, but living better.
The Longevity Connection: Why GLP-1 Matters for Healthy Aging
The relationship between metabolic health and longevity is well-established. Here’s why optimizing GLP-1 function could be a powerful longevity strategy:
Glycemic Control and Aging: Chronic hyperglycemia and insulin resistance accelerate aging through multiple mechanisms, including advanced glycation end products (AGEs), oxidative stress, and chronic inflammation. By improving glucose regulation, enhanced GLP-1 activity may slow these degenerative processes.
Weight Management: Excess visceral fat is strongly associated with reduced healthspan and lifespan. There is strong. evidence that GLP-1’s appetite-suppressing and metabolism-enhancing effects can help maintain healthy body composition throughout the aging process.
Cardiovascular Protection: Emerging research suggests GLP-1 has direct cardiovascular benefits beyond its metabolic effects, possibly protecting against heart disease – still the leading cause of death globally.
Neuroprotection: Intriguingly, GLP-1 receptors are found throughout the brain, and some research suggests GLP-1 may have neuroprotective properties relevant to cognitive aging.
In sum, supporting your body’s natural GLP-1 system could be a key part of a multi-faceted approach to healthier aging.
The Pharmaceutical Approach: Promise and Limitations
The success of GLP-1 medications has been nothing short of remarkable. Drugs like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) work by mimicking or enhancing GLP-1 activity, leading to substantial weight loss and improved metabolic markers in clinical trials.
The Benefits
- Proven Effectiveness: Clinical trials show significant weight loss (15-20% of body weight in many cases)
- Improved Metabolic Markers: Better blood sugar control, reduced A1C in diabetics
- Cardiovascular Benefits: Some formulations show reduced cardiovascular events
- Medical Supervision: Prescribed and monitored by healthcare providers
The Challenges
Cost: For many people, this is a significant barrier. These medications can cost $900-$1,500+ per month without insurance coverage. Even with insurance, copays can be substantial. For a lifelong intervention, this represents a massive financial commitment.
Side Effects: While generally well-tolerated, GLP-1 medications can cause:
- Gastrointestinal issues (nausea, vomiting, diarrhea, constipation)
- Potential for rapid muscle loss alongside fat loss (see “Known Side Effects”, below)
- Rare but serious risks including pancreatitis and gallbladder issues
- “Ozempic face” – the appearance of facial aging due to rapid fat loss
- Rebound weight gain if discontinued
Accessibility: Supply constraints have made these medications difficult to obtain. Many people face long waitlists or can’t access them at all.
Lifelong Dependency: Most people regain weight after stopping these medications, suggesting they may need to be continued indefinitely.
Unknown Long-Term Effects: While short and medium-term data look promising, we don’t yet have 20-30 year safety data on continuous use.
For many people interested in longevity, the question becomes: Is there a more sustainable, natural approach that works with similar mechanisms?
Known Side Effects of the Pharmaceutical Approach
- One side effect that many people appear to be unaware of is that GLP-1 drugs, like other methods of rapid weight loss, can lead to the loss of both fat and muscle mass.
- While they are effective at reducing fat, studies show that a significant portion of the total weight lost can be lean body mass, which includes muscle.
- Some research indicates this can be up to 15-40% of total weight loss, depending on the individual. This can be particularly problematic for the elderly, who are already in danger of losing muscle as the age.
Enter Allulose: The Natural GLP-1 Enhancer
Allulose (also called D-psicose) is a rare sugar that exists naturally in small quantities in foods like figs, raisins, and maple syrup. It has about 70% the sweetness of regular sugar but contains approximately 90% fewer calories and doesn’t significantly impact blood glucose.
But what makes allulose particularly interesting are several recent studies showing that it’s a potent natural stimulator of GLP-1 secretion.
The Evidence
The research on allulose and GLP-1 is surprisingly robust. Let’s look at what we know:
GLP-1 Stimulation is Real and Significant
A June 2024 study published in the journal Nutrients examined rats fed a Western diet (high-fat, high-sugar) for 12 weeks. The group receiving allulose supplementation showed significantly elevated GLP-1 levels throughout the entire trial period.
Remarkably, these rats also experienced reduced body weight gain, improved insulin sensitivity, and better glucose control compared to controls – despite being on the same unhealthy diet.
A 2018 study published in Nature Communications identified allulose as a “prominent GLP-1 releaser” that works through vagal nerve pathways (the communication network between your gut and brain). The researchers found that allulose not only triggered GLP-1 release but that this led to reduced food intake and improved glucose tolerance.
When administered at specific times of day, chronic allulose supplementation actually corrected obesity, abnormal eating patterns, and diabetes in animal models.
Multiple Mechanisms at Work
What’s fascinating is that allulose appears to stimulate GLP-1 through several distinct mechanisms:
Intestinal Distension: A January 2025 study in Endocrinology revealed that allulose’s poor absorbability creates physical expansion in the intestines. This mechanical stretching triggers GLP-1 secretion – a completely novel mechanism. The researchers found that GLP-1 response correlated directly with intestinal content volume and diameter.
Direct Gut Sensor Activation: A 2018 study in Biochemical and Biophysical Research Communications found that oral (but not intraperitoneal) allulose administration elevated plasma GLP-1 levels for more than 2 hours in a dose-dependent manner. The effects were higher than those produced by glucose, fructose, or other carbohydrates.
Central Nervous System Effects: Research published in 2022 showed that allulose doesn’t just work peripherally – it also directly activates neurons in the brain’s appetite control centers (the arcuate nucleus) and enhances their sensitivity to GLP-1 signals. This suggests a synergistic effect between allulose-triggered GLP-1 release and enhanced response to that GLP-1.
Duration and Potency: Unlike many dietary interventions that show transient effects, allulose’s GLP-1-stimulating properties appear sustained. Studies show elevated GLP-1 levels lasting 2+ hours after consumption, with effects persisting throughout multi-week interventions.
Human Studies Show Promise
While much of the work has been done in animal models, human studies are emerging and show encouraging results. A 2023 systematic review and meta-analysis published in PLOS ONE examined acute blood glucose responses in healthy humans consuming allulose. The studies demonstrated that allulose effectively attenuates postprandial (after-meal) blood glucose spikes compared to controls.
While this review noted that more research examining insulin and GLP-1 markers specifically in humans would be valuable, the blood glucose results are consistent with enhanced GLP-1 activity in humans.
A March 2025 comparative study in Nutrients found that several rare sugars including allulose, D-tagatose, and D-sorbose all effectively suppressed food intake through promoting GLP-1 secretion, demonstrating their potential for preventing and ameliorating type 2 diabetes, obesity, and related diseases.
How Allulose Compares to Pharmaceutical GLP-1 Approaches
Putting it in perspective:
Mechanism:
- Pharmaceuticals: Provide synthetic GLP-1 analogs or enhance GLP-1 by blocking its breakdown
- Allulose: Stimulates your body’s own natural GLP-1 production through multiple pathways
Cost:
- Pharmaceuticals: $900-$1,500+ per month
- Allulose: Approximately $15-30 per pound, with typical usage being modest amounts (a few grams per serving) (the amount used in one recent human study which found benefits was 4 g, or 2 teaspoons, twice a day)
Side Effects:
- Pharmaceuticals: Nausea, GI issues, potential muscle loss, rare serious complications
- Allulose: Generally well-tolerated; may cause mild GI discomfort at very high doses (>0.5g/kg body weight), but this is uncommon at typical consumption levels
Accessibility:
- Pharmaceuticals: Requires prescription, subject to supply constraints, insurance barriers
- Allulose: Available as a food ingredient, no prescription needed
Long-term Sustainability:
- Pharmaceuticals: Dependency likely; weight often rebounds when discontinued
- Allulose: Can be incorporated into regular diet as part of sustainable lifestyle changes
Effectiveness:
- Pharmaceuticals: Well-documented, potent effects (15-20% weight loss in trials)
- Allulose: Effects likely more modest but still meaningful; promotes natural satiety and metabolic function rather than pharmacological suppression
Evidence::
- Pharmaceuticals: Large-scale human clinical trials with thousands of participants
- Allulose: Strong mechanistic evidence and animal studies; more human studies are needed
The Balanced Perspective: Strengths and Limitations
Strengths of the Allulose Approach:
- Natural and Physiological: Works by enhancing your body’s own systems rather than overriding them
- Multi-Mechanism: Operates through multiple complementary pathways (distension, vagal activation, central effects)
- Low Risk: Excellent safety profile with minimal side effects
- Accessible: No prescription needed, affordable, readily available
- Sustainable: Can be integrated into normal eating patterns long-term
- Additional Benefits: Beyond GLP-1 effects, allulose doesn’t spike blood sugar and has near-zero calories
Current Limitations:
- Less Human Data: While animal research is compelling, we need more large-scale human clinical trials
- Effectiveness: The effect size in humans for weight loss and metabolic improvements needs better quantification. The available evidence suggests that GLP-1 drugs have a larger and more immediate effect.
- Not a Medical Treatment: Allulose is a food ingredient, not a pharmaceutical intervention for existing disease
- Individual Variation: Response likely varies by individual, gut microbiome, diet context, etc.
- Optimal Dosing Unknown: We don’t yet have precise human dosing guidelines for maximizing GLP-1 effects. With that said, one recent study found benefits from taking 4 g, or 1 teaspoon, twice a day. Other studies suggest that there could be greater benefits in taking significantly more. At this time, an optimal dose for humans is not known.
Who Might Benefit?
Based on the current evidence, allulose appears particularly promising for:
- People focused on metabolic health and longevity who want to support natural GLP-1 function through diet
- Those seeking to maintain healthy weight through sustainable, physiological approaches
- Individuals with prediabetes or metabolic syndrome looking for dietary interventions (in consultation with healthcare providers)
- Anyone wanting to reduce sugar intake while maintaining sweetness and potentially gaining metabolic benefits
- People interested in appetite regulation and reducing cravings naturally
- Those who cannot access or afford GLP-1 medications but want to work with similar mechanisms
- Individuals concerned about pharmaceutical side effects who prefer food-based approaches
Practical Considerations
If you’re interested in experimenting with allulose, here are some practical insights:
Dosing: Animal studies typically used doses around 0.1-3 g/kg body weight. For a 70kg (154 lb) person, this translates to roughly 7-200g, though most studies showing effects used the lower to middle range. Starting with small amounts (5-10g per day) and gradually increasing while monitoring response is sensible.
Timing: Some research suggests timing matters. The chronotherapeutic effects observed in studies involved consumption at the beginning of eating periods. Taking allulose before meals may optimize its GLP-1-releasing effects.
Form: Allulose is available as a granulated sweetener and can be used in beverages, baking, or cooking. Some commercial products (like certain ice creams) now include allulose as their primary sweetener.
Tolerance: Most people tolerate allulose well. At very high doses (above 0.5g/kg body weight in a single dose), some individuals may experience mild digestive effects, but this is uncommon at typical consumption levels.
Realistic Expectations: View allulose as one tool in a comprehensive approach to metabolic health – not a magic bullet. Combine it with whole foods nutrition, regular physical activity, quality sleep, and stress management for optimal results.
The Future: Where Research is Headed
The allulose-GLP-1 connection is still being actively investigated. Here’s what we can expect:
Human Clinical Trials: Larger, longer-term studies specifically examining allulose’s effects on body weight, appetite, metabolic markers, and GLP-1 levels in humans are likely forthcoming.
Mechanistic Clarity: Researchers are working to fully understand all the pathways through which allulose exerts its effects.
Optimal Formulations: Studies may explore combinations of allulose with other compounds that enhance GLP-1 signaling or metabolic health.
Personalization: We’ll likely gain insights into which individuals respond best to allulose based on genetics, microbiome composition, or other factors.
Long-term Outcomes: Following cohorts consuming allulose over years or decades will help us understand its role in healthy aging and longevity.
What I’m Doing
I take a powder which is made up of both allulose and monk fruit, another natural sweetener. I’m currently taking four teaspoons a day, with meals that included carbohydrates. For example, I had some wild blueberries in the Greek yoghurt this morning; the carb count for this meal was about 15 g of net carbs; I added two teaspoons or 8 g of allulose. This may not be the optimal dose; more human studies should clarify what amount is most beneficial. If I’m eating a meal with no carbohydrates, such as scrambled eggs with bacon, I don’t usually take allulose along with it.
Conclusion: A Promising Natural Approach
The evidence connecting allulose to enhanced GLP-1 function is striking and is growing rapidly. While we need more extensive human research to fully understand its potential, the existing data suggests that allulose represents a rare example of a natural compound that works through similar mechanisms to pharmaceutical interventions.
For those interested in longevity and metabolic optimization, allulose offers an intriguing option: a way to work with your body’s natural signaling systems, promoting satiety, improving glucose regulation, and potentially supporting healthier aging – all through a simple dietary modification.
I’m not suggesting that allulose is necessarily a replacement for medical treatment. But as part of a comprehensive approach to healthspan and longevity, for those without medical conditions, allulose may be one of the most underappreciated tools available. If you’re taking a pharmaceutical GLP-1 enhancer, be sure to tell your doctor if you start taking allulose, as they may want to adjust or even eliminate your medication.
The pharmaceutical GLP-1 revolution has taught us how powerful this metabolic pathway is. Allulose suggests that we may be able to tap into that same power through the foods we choose – naturally, sustainably, and accessibly.
References
Key studies referenced in this article:
- Cayabyab KB, et al. (2024). “The Metabolic and Endocrine Effects of a 12-Week Allulose-Rich Diet.” Nutrients, 16(12):1821.
- Mizuma S, Hayakawa M, Hira T. (2025). “Intestinal Distension Induced by Luminal D-allulose Promotes GLP-1 Secretion in Male Rats.” Endocrinology, 166(2):bqaf002.
- Iwasaki Y, et al. (2018). “GLP-1 release and vagal afferent activation mediate the beneficial metabolic and chronotherapeutic effects of D-allulose.” Nature Communications, 9:113.
- Hayakawa M, et al. (2018). “Secretion of GLP-1 but not GIP is potently stimulated by luminal d-Allulose (d-Psicose) in rats.” Biochemical and Biophysical Research Communications.
- Yermek R, et al. (2022). “D-Allulose cooperates with glucagon-like peptide-1 and activates proopiomelanocortin neurons in the arcuate nucleus and central injection inhibits feeding in mice.” Biochemical and Biophysical Research Communications, 616:129-133.
- Tani Y, et al. (2023). “Allulose for the attenuation of postprandial blood glucose levels in healthy humans: A systematic review and meta-analysis.” PLOS ONE.
- Masuda Y, et al. (2025). “Abilities of Rare Sugar Members to Release Glucagon-like Peptide-1 and Suppress Food Intake in Mice.” Nutrients, 17(7):1221.
Note: This article is for educational and informational purposes only and does not constitute medical advice. Always consult with qualified healthcare providers before making significant changes to your diet or health regimen, especially if you have existing medical conditions or are taking medications.
Not medical advice
This article is not intended as, and should not be taken as, medical advice. I’m not advising that people eat any particular diet or take any particular supplement(s), just reporting on what I’m doing. Supplements, like medications and other interventions, can have side effects; I would encourage people to research both possible benefits and side effects before starting on any supplementation regimen, and consult with a medical professional about any issues which might have a medical component. See full Medical Disclaimer
Other resources
- My Youtube channel Pathways to Longevity
- My Facebook group: Anti-Aging and Life Extension,
